Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation NY Valves 2024

Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients

Presenter: Nino Mihatov

June 07, 2024

Presentation NY Valves 2024

How to Define and Manage Subclinical Leaflet Thrombosis

Presenter: Hasan Jilaihawi

June 07, 2024

Presentation NY Valves 2024

Histopathology From Explanted Valves in Patients With HALT and RLM

Presenter: Stephanie Sellers

June 07, 2024

Presentation NY Valves 2024

Arial View of Antithrombotic Therapy Post TAVR

Presenter: Thomas Pilgrim

June 07, 2024

Presentation NY Valves 2024

What is the Optimal Post-LAAO Antithrombotic Regimen?

Presenter: Sameer Gafoor

June 07, 2024

Presentation NY Valves 2024

Valve Thrombosis and Antithrombotic Therapy After Surgical and Transcatheter Mitral Valve Replacement: A Systematic Review and Meta-Analysis

Presenter: Mark Zorman

June 06, 2024

Presentation TCT 2023

Prophylactic Antithrombotic Therapy After TAVR

Presenter: Christian Hengstenberg

October 25, 2023

Presentation TCT 2023

TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients After Transcatheter Aortic Valve Implantation

Presenter: Daniel Overduin

October 24, 2023

Presentation TCT 2022

TCT 384: Real-World Practices in the Use of and Adherence to Antithrombotic and Antiplatelet Therapies Before and After Left Atrial Appendage Closure

Presenter: Jennifer Rymer

September 18, 2022

Presentation TVT 2022

Optimal antithrombotic regimen after transcatheter aortic valve replacement (TAVR): long term follow-up study

Presenter: Melissa Moey

June 09, 2022

Presentation TCT 2021

Evidence-Based Antiplatelet and Antithrombotic Therapy for TAVR

Presenter: Stephan Windecker

November 05, 2021

Presentation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

August 20, 2019

Presentation TVT 2019

Echocardiographic Surveillance and Antithrombotic Therapy After LAA Closure

Presenter: Jacqueline Saw

June 13, 2019

Presentation TCT 2018

Antithrombotic Therapy in Patients Undergoing TAVR

Presenter: Jeroen J. Bax, Stephan Windecker

September 21, 2018

Presentation TCT 2017

Antithrombotic Therapy Considerations After TMVR: What Can We Learn From the Surgical Experience?

Presenter: Vinayak Bapat, Maurice Buchbinder

October 31, 2017

Presentation TCT 2017

Case Comments: What Antithrombotic/Antiplatelet Regimen Should We Start?

Presenter: Nick Curzen, Rod H. Stables, Alexey Protopopov

October 31, 2017

Presentation CRT 2017

Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

Presenter: Chadi Alraies

February 22, 2017

Presentation TCT 2016

Controversy 5. Adjunctive Pharmacotherapy for TAVR: Real World Usage Patterns of Antiplatelet and Antithrombotic Agents

Presenter: Raj Makkar, Lars Sondergaard, Luis Nombela-Franco

October 31, 2016

Presentation TCT 2016

TCT 27: Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-Implant Antithrombotic Therapy

Presenter: Zahid Amin, Jacqueline Saw, Jens Erik Nielsen-Kudsk

October 31, 2016

Advertisement

Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients

How to Define and Manage Subclinical Leaflet Thrombosis

Histopathology From Explanted Valves in Patients With HALT and RLM

Arial View of Antithrombotic Therapy Post TAVR

What is the Optimal Post-LAAO Antithrombotic Regimen?

Valve Thrombosis and Antithrombotic Therapy After Surgical and Transcatheter Mitral Valve Replacement: A Systematic Review and Meta-Analysis

Prophylactic Antithrombotic Therapy After TAVR

TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients After Transcatheter Aortic Valve Implantation

TCT 384: Real-World Practices in the Use of and Adherence to Antithrombotic and Antiplatelet Therapies Before and After Left Atrial Appendage Closure

Optimal antithrombotic regimen after transcatheter aortic valve replacement (TAVR): long term follow-up study

Evidence-Based Antiplatelet and Antithrombotic Therapy for TAVR

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

Echocardiographic Surveillance and Antithrombotic Therapy After LAA Closure

Antithrombotic Therapy in Patients Undergoing TAVR

Antithrombotic Therapy Considerations After TMVR: What Can We Learn From the Surgical Experience?

Case Comments: What Antithrombotic/Antiplatelet Regimen Should We Start?

Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

Controversy 5. Adjunctive Pharmacotherapy for TAVR: Real World Usage Patterns of Antiplatelet and Antithrombotic Agents

TCT 27: Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-Implant Antithrombotic Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content